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Introduction: ETS1 is a negative regulator of the Th17 differentiation gene and plays a central role in the
pathogenesis of autoimmune diseases. We aimed to investigate whether polymorphisms in ETS1 confer
susceptibility to ankylosing spondylitis (AS) in Han Chinese.
Methods: We selected seven single nucleotide polymorphisms (SNPs) within ETS1 based on HapMap data and
previous genome-wide association study. Genotyping involved the TaqMan method in 1,015 patients with AS
and 1,132 healthy controls from Shandong Province, and 352 AS patients and 400 healthy controls from Ningxia,
a northwest region in China. Gene expression was determined by real-time PCR.
Results: The SNP rs1128334 was strongly associated with AS (odds ratio 1.204, 95% confidence interval 1.06-1.37;
P = 0.005). This association was confiexrmed in the Ningxia population (P = 0.015). Carriers of the haplotype TAT for
rs12574073, rs1128334 and rs4937333 were associated with increased risk of AS and haplotype CGC with reduced
risk as compared to controls. In addition, ETS1 expression was lower in AS patients than controls. The risk allele
A of rs1128334 and haplotype A-T of rs1128334 and rs4937333 were associated with decreased expression of ETS1.
Conclusions: Common variants in ETS1 may contribute to AS susceptibility in Han Chinese people.Introduction
Ankylosing spondylitis (AS) is a common inflammatory
arthritis that affects the axial skeleton and peripheral
joints [1]; it is usually accompanied by lower back pain,
peripheral arthritis, enthesis and iritis, and even spinal
deformity and ankylosis, ultimately limiting the mobility
of the spine and other joints [2]. Genetic factors are
strongly implicated in the pathogenesis of the disease,
and the estimated heritability is up to 97% according to
a twin study [3,4].
The major histocompatibility complex (MHC), mostly
from human leukocyte antigen B27 (HLA-B27), accounts
for nearly half of the predisposition for AS [5]. Although
HLA-B27 is strongly associated with risk of AS, its asso-
ciated genes account for only 20% to 30% of the overall
genetic risk of AS [1]. Thus, other loci may be involved.
Besides HLA-B27, non-MHC genes implicated in the risk* Correspondence: liuqiji@sdu.edu.cn
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unless otherwise stated.of AS include ERAP1, KIF21B, IL23R and two intergenic
regions at chromosome 2p15 and chromosome 21q22 in a
European population [6,7].
Two recent genome-wide association studies (GWASs)
of an Asian population demonstrated a novel region
containing ETS1 at chromosome 11q23 strongly associ-
ated with systemic lupus erythematosus (SLE) [8,9].
rs6590330, rs1128334 and rs4937333 were identified as
the susceptible variants associated with SLE. Subse-
quently, many genetic studies reported that rs11221332
of ETS1 is associated with rheumatoid arthritis (RA) and
celiac disease, both characterized by excessive activation
of the immune system [10,11]. Also, increasing evidence
has suggested that many of the known AS-associated
loci overlap with those of other immune-related diseases.
Because of clinical and immunological overlap of AS
and other autoimmune diseases [12], ETS1 may be asso-
ciated with AS as well. In this study, we investigated the
association of ETS1 genetic polymorphisms and AS in
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Subjects
We recruited 2,899 unrelated subjects in this case-control
study from 2008 to 2011, including 1,015 patients (701
male, 69.1%) with AS from Shandong Provincial Hospital
and Qilu Hospital in Jinan, Shandong province. All pa-
tients, at a mean age of 38 ± 8.3 years, had no history of
inflammatory bowel disease and/or psoriasis and met the
modified New York criteria for AS. We also recruited
1,132 unrelated, randomly sampled healthy controls (603
male, 53.3%) from a health check-up center at the hospital
during the same period; the mean age was 40 ± 7.2 years
old. All subjects were ethnic Han living in Shandong, an
eastern coastal province of North China. More detailed in-
formation about the samples was reported previously [13].
The replication samples of 352 AS patients and 400 con-
trols from Ningxia (a province in northwest China) were
provided by Professor Yang Ze, with detailed information
[14]. Flow cytometry was used to immunophenotype
HLA-B27 in patients and controls, and only HLA-B27-
positive patients and HLA-B27-negative controls were
recruited.
Genomic DNA from peripheral blood leukocytes was
extracted by a standard phenol-chloroform method. The
study was approved by the ethics committee for human
studies at the Shandong University School of Medicine,
and all subjects provided their informed consent.
Sequence analysis of the human ETS1 gene
All nine coding exons and 1,000 bp of the 5′ upstream se-
quence of ETS1 were sequenced in DNA samples from
100 AS cases to screen for genetic variants. ETS1 was
amplified by PCR before sequencing. The PCR reaction
was run in a total volume of 50 μL solution containing 5 ×
PCR buffer, 10 μL; 5 × dNTP (1 mmol/L each of dATP,
dTTP, dGTP and dCTP), 10 μL; 50 ng genomic DNA; 0.4
μM of each primer; and 1 U Taq DNA polymerase. The
PCR amplification conditions were optimized with an ini-
tial denaturation step at 94°C for 5 minutes followed by 35
cycles of 94°C for 40 sec, optimal annealing temperature
for 40 sec, extension at 72°C for 40 sec and a final exten-
sion step of 72°C for 10 minutes. All sequencing was
performed by the Genomic Analysis Facility (Shenzhen
Huada, Shenzhen, China) and analyzed with use of
Chromas 2.33 software.
Single nucleotide polymorphism (SNP) selection and
genotyping
Because we were unable to detect novel variants in the se-
quencing region, we selected seven SNPs (rs12574073,
rs1128334, rs4937333, rs4254089, rs7951925, rs7116578
and rs4937342) in ETS1 with minor allele frequency ≥0.05
and r2 >0.8 in data for Han Chinese in Beijing (HCB) in
HapMap [15] and genotyped by TaqMan SNP genotypingassay using assay-on-demand probes and primers
(C_31697960_10 for rs12574073, C_7539918_10 for
rs1128224, C_278298_10 for rs4937333, C_449693_10 for
rs4254089 C_220576_10 for rs7951925, C_29363433_10
for rs7116578, C_27979762_20 for rs4937342; Applied
Biosystems, Foster City, CA, USA). rs1128334 and
rs4937333 were reported to be strongly associated with
SLE and were therefore selected and investigated. We also
selected rs12574073 as a candidate SNP because it was a
proxy SNP for rs6590330, demonstrated to be associated
with SLE in a previous GWAS [9]. The locations of these
SNPs are shown in Figure 1. All genotyping involved use
of the Lightcycler 480 real-time PCR system (Roche,
Mannheim, Germany). The PCR reaction was run in a
total volume of 5 μL solution containing 2 × Premix EX
Taq (Takara, Otsu, Shiga, Japan), 2.5 μL; >10 ng genomic
DNA; 2.5 μM of each primer; and 0.05 μL probes. The
PCR amplification conditions were 95°C for 30 sec, 45 cy-
cles of 95°C for 5 sec, 60°C for 20 sec and 40°C for 30 sec
for cooling. Genotyping accuracy in the samples was con-
firmed by direct sequencing of PCR products for 5% of
randomly chosen samples.
RT-PCR
Total peripheral leukocyte RNA was extracted from 50
AS patients and 161 healthy controls by the TRIzol re-
agent method (Invitrogen, Carlsbad, CA, USA), then under-
went reverse transcription by use of a reverse transcript kit
(Takara, Otsu, Shiga, Japan). Allelic-specific expression of
ETS1 was analyzed only in healthy controls. RNA samples
were treated with RNase free DNAase to eliminate genomic
DNA contamination before being reverse-transcribed into
cDNA. Real-time quantitative RT-PCR to amplify cDNA
involved the Roche 480 real-time PCR system with SYBR
Green Master Mix (Applied Biosystems, Foster City, CA,
USA). Relative expression was analyzed by the com-
parative threshold cycle (Ct) method and normalized to
that of human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), calculated by the 2-△△Ct method and log10
transformed. The primer sequences for ETS1 were sense
5′-TACACAGGCAGTGGACCAATC-3′ and antisense
5′-CCCCGCTGTCTTGTGGATG-3′; and GAPDH, sense
5′-CCAGGTGGTCTCCTCTGACTT-3′ and antisense
5′-GTTGCTGTAGCCAAATTCGTTGT-3′. Melting curve
analysis was used to confirm specificity, with four dupli-
cate wells used for each subject [16].
Statistical analysis
The SNPs were tested for adherence to Hardy-Weinberg
equilibrium (HWE) by chi-square test. Comparison of the
allele frequency of the seven SNPs for patients and controls
involved Fisher’s exact test with use of Plink 1.07 [17]. The
Bonferroni correction was used for multiple test correc-
tion. Pairwise linkage disequilibrium (LD) was measured
Figure 1 Schematic location of seven single nucleotide polymorphisms (SNPs) in the ETS1 gene.
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calculated by use of a full precise-iteration algorithm with
the online SHEsis software [18]. Differences in allelic ex-
pression were tested by t-test and analysis of variance
(ANOVA) by use of GraphPad Prism v5.01 (GraphPad




To search for new variants in the ETS1 gene, we se-
quenced all exons including the untranslated region
(UTR) and 5′ upstream regulatory region. However, no
novel variant was found in any of the nine exons or
1,000 bp of the upstream sequence.
Association study
We obtained allele, genotype and haplotype distributions
for seven markers in ETS1 in chromosome 11q23 for
1,132 controls and 1,015 patients with AS in Shandong.
The allele frequency for each SNP was analyzed (Table 1),
and none deviated significantly from HWE, as deter-
mined at the 0.05 significance level. Frequency of the
rs1128334 allele A was significantly higher in AS pa-
tients (P = 0.005, odds ratio (OR) 1.204, 95% CI 1.06,
1.37) than in healthy controls. Even after the Bonferroni
correction, the association remained significant (Pc =
0.035). rs12574073 and rs4937333 were associated with
AS but not after the Bonferroni correction. Then, we
replicated the associated SNP rs1128334 in the Ningxia
cohort of 352 cases and 400 matched controls. The minor
allele frequency of rs1128334 was greater for cases than
controls (P = 0.015, OR 1.31, 95% CI 1.06, 1.62).
LD evaluation and haplotype analysis
rs1128334 was in strong LD with rs12574073 (r2 = 0.95)
(Figure 2). We identified eight different haplotypes in the
studied population, but only three showed frequency >3%
(Table 2). As expected, the haplotype results were similar
to the single-site association results, and haplotype TAT
formed by rs12574073, rs1128334 and rs4937333 wasstrongly associated with increased risk of AS (OR 1.24,
95% CI 1.05, 1.47, P = 0.01), whereas haplotype CGC re-
duced the risk (OR 0.82, 95% CI 0.70, 0.96, P = 0.01).
mRNA expression of ETS1 in peripheral blood
mononuclear cells (PBMCs)
We examined the mRNA levels of ETS1 in 50 AS pa-
tients and 161 healthy controls. Relative ETS1 mRNA
expression was lower in cases than controls (P <0.0001,
Figure 3).
Allelic-specific expression of ETS1
To determine whether rs1128334 was associated with
ETS1 expression, we genotyped 161 healthy control sam-
ples for rs1128334 to compare the ETS1 expression in
subjects with different genotypes of the SNP. ETS1
mRNA level was lower in AA (n = 28) and AG (n = 50)
than GG (n = 83) homozygotes (P <0.01, Figure 4).
Thus, carriers with the risk allele A of rs1128334 may
exhibit significantly lower ETS1 mRNA expression than
those with the allele G. In addition, analysis of healthy
controls involved only rs1128334 and rs4937333 because
of the high LD between rs12574073 and rs1128334 (r2 =
0.95, Figure 2). Subjects carrying haplotype A-T (n = 28)
for rs1128334/rs4937333 had a significantly lower level of
ETS1 than those carrying haplotype GC (n = 69) (P <0.05,
Figure 5).
Discussion
We have demonstrated that ETS1 is associated with AS,
thus adding to the list of loci showing overlap between
AS, RA and SLE. We identified an SNP, rs1128334, lo-
cated in the 3′ UTR of ETS1, which was significantly
associated with AS in Han Chinese people. We also
showed a lower expression of ETS1 in peripheral leuko-
cytes from patients than controls. Furthermore, the risk
allele of rs1128334 and the risk haplotype A-T of
rs1128334 and rs4937333 were significantly linked to de-
creased mRNA level of ETS1. To our knowledge, this is
the first report demonstrating an association of ETS1
polymorphisms and AS in Han Chinese. Especially, we
Table 1 Genotype and allele association analysis of seven single nucleotide polymorphisms (SNPs) in samples of AS in
Shandong and rs1128334 in Ningxia
Population SNPs Position Genotype/allele Patients, number (%) Controls, number (%) Odds ratio 95% CI P-value P*
rs12574073 128319478 CC 423 (42.7) 401 (47.8) 1
CT 457 (46.1) 356 (41.8) 1.217 1.002, 1.478 0.192
TT 111 (11.2) 89 (10.4) 1.182 0.867, 1.613
C 1,303 (65.7) 1,170 (68.7) 1
T 679 (34.3) 534 (31.3) 1.142 0.994, 1.311 0.062
rs1128334 128328959 GG 417 (42.2) 528 (48.0) 1
AG 457 (46.3) 471 (42.8) 1.229 1.024, 1.473 0.018
AA 114 (11.5) 101 (9.2) 1.429 1.062, 1.923
G 1,291 (65.3) 1,527 (69.4) 1
A 685 (34.7) 673 (30.6) 1.204 1.058, 1.371 0.005 0.035
rs4937333 128330520 TT 183 (18.2) 177 (15.6) 1
CT 483 (48.0) 535 (42.3) 0.873 0.687, 1.111 0.160
CC 341 (33.8) 420 (37.1) 0.785 0.611, 1.010
T 849 (42.2) 889 (39.3) 1
C 1165 (57.8) 1375 (60.7) 0.887 0.785, 1.003 0.057
Shandong rs4254089 128366221 CC 64 (6.3) 66 (5.9) 1
CT 356 (35.1) 365 (32.9) 1.006 0.692, 1.461 0.478
TT 595 (58.6) 680 (61.2) 0.902 0.629, 1.295
C 484 (23.8) 497 (22.4) 1
T 1546 (76.2) 1725 (77.6) 0.920 0.798, 1.062 0.259
rs7951925 128379964 AA 84 (8.3) 109 (9.7) 1
AG 420 (41.4) 444 (39.6) 1.227 0.896, 1.681 0.433
GG 510 (50.3) 569 (51.7) 1.163 0.854, 1.584
A 588 (29.0) 662 (29.5) 1
G 1,440 (71.0) 1,582 (70.5) 1.025 0.898, 1.169 0.736
rs7116578 128388773 AA 869 (85.9) 970 (86.3) 1
AG 133 (13.1) 145 (12.9) 1.024 0.795, 1.318 0.884
GG 10 (1.0) 9 (0.8) 1.240 0.502, 3.066
A 1,871 (92.4) 2,085 (92.7) 1
G 153 (7.6) 163 (7.3) 1.046 0.832, 1.316 0.726
rs4937342 128398309 TT 903 (89.8) 993 (90.2) 1
TG 101 (10.0) 102 (9.3) 1.089 0.815, 1.455 0.368
GG 2 (0.2) 6 (0.5) 0.367 0.074, 1.821
T 1,907 (94.8) 2,088 (94.8) 1
G 105 (5.2) 114 (5.2) 1.008 0.768, 1.324 1.000
Ningxia rs1128334 128328959 GG 135 (38.4) 190 (47.5) 1
AG 168 (47.7) 166 (41.5) 1.424 1.047, 1.938 0.038
AA 49 (13.9) 44 (11.0) 1.576 0.986, 2.490
G 438 (62.2) 546 (68.2) 1
A 266 (37.8) 254 (31.8) 1.305 1.055, 1.615 0.015
*Adjusted P-value after Bonferroni correction.
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Figure 2 Linkage disequilibrium of seven single nucleotide polymorphisms (SNPs) in the ETS1 gene. Left, D’. Right, r2.
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ulations, Han Chinese from Shandong and Ningxia,
which enhances the credibility of our findings.
In previous reports, the common variants rs1128334,
rs4937333 and rs6590330 were found to be significantly
associated with SLE in east Asian populations. In
addition, rs11221332 was suggested to be strongly asso-
ciated with celiac disease in a European population and
RA in a Caucasian population. In agreement with these
studies of autoimmune diseases, we observed that ETS1
was also a susceptibility gene for AS at least in northern
Han Chinese. Our findings provide support for many
autoimmune diseases sharing the same susceptibility loci.
ETS1 encodes a member of the ETS family of tran-
scription factors that activate transcription by binding to
cis-regulatory elements in target genes [19,20]. The
ETS1 transcription factor was initially discovered as the
proto-oncogene corresponding to v-ets of the avian
erythroblastosis virus (E26) [19,21], which harbors a
conserved DNA-binding domain mediating specific
DNA binding to the GGAA/T motif [20]. As a crucial
transcription factor widely expressed in lymphocytes and
vascular endothelial, lacteal glandular epithelium and
various invasion tumor cells, ETS1 regulates the devel-
opment, senescence and death of many immune cells
[22,23]. It also plays a role in both innate and adaptive
immune response [23,24]. Accumulating evidence pointsTable 2 Haplotype frequencies of three single nucleotide pol
Haplotype No. (%) of patients No. (%) of
T A T 478.82 (0.334) 345.87
C G C 825.82 (0.577) 749.74
C G T 112.17 (0.078) 93.24 (
The order of three SNPs: rs12574073, rs1128334, rs4937333.to an important role for ETS1 in regulating the differen-
tiation of immune cells such as T-cell differentiation into
a helper population, terminal differentiation of B cells,
development of natural killer (NK) cells and NK T cells
and the expression of cytokine and chemokine genes in
a wide variety of different cell lineages [24-27]. Animal
experiments showed that autoimmune disease developed
in ETS1-knockout mice, as investigated by the produc-
tion of high titers of autoantibodies, and immune cell
infiltration into organs accounted for aberrations in
lymphocyte differentiation [24].
In addition to roles in controlling the production of
interferon-gamma in T helper (Th)1 cells [28] and driv-
ing normal Th2 cytokine production, ETS1 is also in-
volved in the Th17 cell lineage as a negative regulator of
Th17 cell differentiation [29]. Increasing studies suggest
that Th17 cells are involved in the pathogenesis of AS
[30]. Recently, Zhang et al. examined serum IL-17 levels
from 283 SLE cases and observed a significant syner-
gistic epistatic interaction between two risk variants,
rs10893872 and rs1128334, in the ETS1 gene, and the
haplotype formed by these variants was significantly as-
sociated with serum IL-17 levels in SLE patients [31],
which supports a role for genetic interaction contribut-
ing to the complexity of autoimmune disease [31-33].
From our findings, subjects with AS carrying the risk al-
lele A have significantly lower ETS1 expression than thoseymorphisms in all samples
controls Odds ratio (95% CI) P-value
(0.288) 1.24 (1.05, 1.47) 0.01
(0.624) 0.82 (0.70, 0.96) 0.01
0.078) 1.01 (0.76, 1.35) 0.94
Figure 3 mRNA expression of ETS1 in patients and controls. Figure 5 ETS1 mRNA levels in the carriers of each
rs1128334-rs4937333 haplotype.
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formed by rs12574073, rs1128334 and rs4937333 in ETS1
was significantly associated with AS susceptibility. As well,
individuals carrying haplotype AT for rs1128334/rs4937333
showed less ETS1 expression than those carrying the GC
haplotype. With the HCB data in HapMap, rs10893872
and rs4937333 are in perfect LD (r2 = 1), so our results are
consistent with the Zhang et al. study.
Much evidence has confirmed that microRNAs (miR-
NAs) can regulate gene expression by sequence-specific
binding to target mRNAs, but the binding affinity can
be affected by SNPs residing in miRNA target sites,
which may in turn affect the ability of miRNA to inhibit
the mRNA translation into proteins or lead to degrad-
ation of the mRNA [34]. Indeed, recent research hasFigure 4 Allelic-specific expression of ETS1 by genotypes
of rs1128334.demonstrated that SNPs at miRNA binding sites likely
affect the expression of the miRNA target genes and thus,
may contribute to susceptibility to autoimmune diseases
[35]. Therefore, we presumed that variants rs1128334 and
rs4937333 located in the 3′ UTR of ETS1 may affect
miRNA binding affinity and further influence the expres-
sion of the target gene, which may contribute to suscepti-
bility to AS. However, the detailed mechanism of this
functional relationship requires further investigation.
Conclusions
In summary, our study identified that the common vari-
ants of ETS1 confer susceptibility to AS. This study
might provide further evidence to improve our under-
standing of the exact function of ETS1 in the pathogen-
esis of autoimmune diseases.
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